Loading stock data…
Precipio (PRPO)
$24.28+0.97 (+4.16%)
Market ClosedLast close Jun 29
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Precipio, Inc. in the Healthcare sector is trading at $24.28 with a market capitalization of $40M. The stock is currently 28% below its 52-week high of $33.63, remaining 2.3% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.71M↑ | $6.70M↓ | $6.77M↑ | $5.65M↑ | $4.93M |
| Gross Profit | $2.73M↓ | $3.13M↑ | $3.00M↑ | $2.43M↑ | $2.14M |
| Operating Income | -$1.43M↓ | $542,000↑ | -$61,000↑ | -$824,000↑ | -$859,000 |
| Net Income | -$1.44M↓ | $526,000↑ | -$79,000↓ | $74,000↑ | -$884,000 |
Peer Comparison
JNJUNHPFE
Fundamentals
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagn...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$40.11M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-6.51%
Volume
Today's trading volume
4,766
Recent News
The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio
Caterpillar, Palo Alto Networks and Toyota headline new research as analysts weigh growth drivers, demand trends and risks across key industries.
Top Analyst Reports for Caterpillar, Palo Alto & Toyota
Caterpillar, Palo Alto Networks and Toyota headline Zacks' top analyst reports, highlighting growth drivers, opportunities and key risks shaping outlooks.
Precipio (PRPO) Q1 2026 Earnings Call Transcript
Ilan Danieli: Good afternoon, everyone, and thank you for joining us today for Precipio's Q1 2026 Shareholder Update Call. Before reviewing the quarterly financials for Q1, I'd like to take a moment to step back and discuss where we believe the company is in the execution of its strategy.
Precipio (PRPO) Q4 2025 Earnings Transcript
Need a quote from a Motley Fool analyst? Behind every diagnostic test we run is a patient waiting for answers often during one of the most difficult moments of their lives. While today's discussion will focus primarily on financial performance and operational progress, it's important to remember that these results ultimately represent something that is beyond dollars and cents.
Precipio Stock Slips Post Q1 Earnings Despite Revenue Growth
PRPO's first-quarter 2026 sales are driven by pathology momentum, but CMS reimbursement cuts and higher spending squeeze margins and widen losses.